COMMENTARY
Small
This
Airways
commentary
and
provides
Interstitial
editorial
perspectives
on the
report
which
follows
Pulmonary
Disease
T
he
concept
of disease
introduced
in
of the
1968
by
small
Hogg
airways
and
was
associates.1
These workers defined the site and nature of obstruction of the airways in chronic obstructive pulmonary disease ( COPD ) at the small airways. Morphologically, small ( less than 2 mm ) airways were narrowed or obliterated by inflammation, mucus, or fibrosis. The concept of two components to disease of the small airways was introduced by them, ie, a reversible or mucous due
component plugging
to fibrosis,
ation
of
small
due and an
to acute irreversible
distortion,
and
airways.
These
ly
support
that
airway
the
it is likely
of
alveolar
a distal
septae4
chronic
been
initiated,
the
for
Ostrow
and
of
small
of
unclear;3’4 disease
con-
disrup-
by
evidence airways.
of increased
narrowed
function
of interstitial
had
logic
features,
interstitial
heterogeneous
and
as COPD tilatory volumes, sically
cause
characterized
pulmonary
order
morphologic
of the 470
and
small
observations
airways
FULMER, ROBERTS
is not
clas-
defect
compliance)
to
disease
airflow.6
Be-
defect recent indicate
limited
tissues the con-
in this disphysiologic that
to COPD
disease
and
resistance
20
correlation
small two
made
pulmonary
( interstitial
collagen
of
to be
that
shown
morphologic
from pulmonary vascular
cryoglobulinemia) alterations consistent
can
studies inthis .
that
other
changes
idiopathic disease
that
involve
can dedisease. diseases
can
be
pulmonary
fibro-
associated
with
diseases
may with
useful
idiopathic
that
that physiologic of. small .airways have
of narbiopsy
dynamic cornflow-volume
ie,
disease
17
a good
considered
expiratory a
of
( 94 perinflammation of these
Furthermore,
demonstrated is
18
pulmonary
Seventeen
disease,
maximum
studies
of
between the finding in the specimens from studies
airways and the function
specific
12
study
indistinguishable
mixed logic
had
pulmonary
fibrosis or (71 percent)
small-airway
fibrosis
Subsequent
sis
some in small
study
obtaining testing
airways.12
was seen airways
and
by
patients.12
small
Our
pulmonary
small fine
to airflow
detailed
same
physiologic of
pliance curves.
that
disease
correlative was
the
narrowed
detectors
in
of 29 patients with idiopathic found small airways to be patients (70 percent). A detailed
cent) had peribronchiolar or bronchiolitis, and
and
found
pulmonary
performing in
rowed
and
groups
were
was made subsequently
we
29 patients
with
is characterized
of the supporting interstitium,6
of a restrictive ventilatory is easy to accept. However,
cept
has
a restrictive
obstruction
morphologically by fibrosis of lung, primarily alveolar
and
disease
volumes of
are
causes.#{176} Just
by an obstructive yenor increased pulmonary by
pulmonary interstitial
of
pulmonary
evidence
diseases
a variety
is characterized normal
( reduced
of common cmand morpho-
pulmonary
have
defect with interstitial been
without
because physiologic,
in
and
functional
disease
disease
Cherniack9
physiologic-morphologic tissue
Al-
pulmonary
Both
patho-
that
a study fibrosis
pulmonary
proteases may result in degradation of and subsequent emphysema.5 In contrast to its occurrence in COPD, disease of the small airways was not considered to be a part
recently.
In
Carnngton,8
alveolar
suggestion
interstitial
on
placed
disease. Exinterstitial
and on
airway
al.b0
with
elastin
until
The
et
Yernalt
Liebow
acute by
communicabeen
concentrated
patients
neutrophilic
though grouped together ical, roentgenographic,
macrophagic
by
interstitial
pulmonary obliterans
by
small
1973
original
“bronchiolitis have
in
emphasis
described
interstitial
these
disease
the
in
or
pulmonary
of
cept
their
in interstitial
with
mechanical
release
airways
in has
consistent
to the development of Once this last process
and
alveolitis.
small
Rich7
recently
alterations
role
airway
only
suggested
is
and
and
tion,
pathophysiologic
evident
of small airways in fibrosis was mentioned
abnormalities.
emphysema, small
Hamman
and be
narrowing pulmonary
logic
development
of air
Although idiopathic
may
or obliterbe one of the data strong-
The
morphologic
COPD disease.
reports
eventual
that
to trapping
tributes
has
in
particularly
however, tion
suggestion.24
disease
COPD,
may current
of the of
most
findings
that disease of the small airways earliest changes in COPD, and
many
pneumonia”
inflammation component
narrowing
that
features pulmonary
also disease
and
essential
have physioof the small
airways. 5
CHEST, 77: 4, APRIL, 1980
Granulomatous
interstitial
airways. such
graulomata
with
in
patients
disease Young and associan involvement by
pulmonary
may also involve small ates16 in 1967 demonstrated
sarcoidosis.
Although
evidence of chronic obstruction of airflow an increased residual volume and normal or normal total lung capacity. #{176}’31 Roentgeno-
tional
with near
graphically,
these workers noted no evidence of obstruction to airflow on simple spirometric testing, this publicalion preceded our current concepts of the relative insensitivity of this test to mild degrees of obstruclion to airflow. Subsequent studies have shown that granulomata can involve small airways and that patients with sarcoidosis can have physiologic alter-
coexisting
ations
ease,
consistent
with
disease
of
the
small
air-
20
At least
three
terstitial
occupational or environmental in( hypersensitivity pneumonitis,
diseases
asbestosis,
and
coal
dust
disease)
have
been
shown
chronic
both
morphologic
Simicoal dust the small
many
Although
its
occurrence
small
studies
in
airway
susceptibility
now demonstrated pulmonary disease,
not
always
interstitial
disease
which suggests its occurrence. of the disease
have is
that several factors These factors might process, chronicity of the
host,
and
certain
tal factors.6’12’26’27 The functional disease of the small airways is also it is likely
that
small
airway
present,2 27
must determine include severity of the disease,
disease
environmen-
of
significance
variable. is the
While
earliest
significance of small airway disease in interstitial pulmonary disease is speculative. It is likely that disease of the small airways contributes to the ventilation-perfusion mismatching in interstitial pulmonary disease and hence to the hypoxemia of this disease.6’2 In addition, small airway disease may be partly refunctional
alteration
sponsible
for
pulmonary
in
alterations
volumes4
in for
the
COPD,
pulmonary
example,
recoil trapping
and of
air
may mask the effects of alveolar fibrosis. Perhaps this is why pulmonary volumes correlate poorly or not at all with the severity of fibrosis in interstitial pulmonary fibrosis and in many of the inorganic dust diseases. ’ Disease of the small airways may also contribute to the development of chronic obstruction of airflow in interstitial pulmonary disease. Indeed,
it
is well
documented
but
poorly
recog-
nized that some patients with interstitial pulmonary disease progress to show a pattern of chronic obstruction of airflow. The most notable example is chronic sarcoidosis, in which there may be func-
CHEST, 77: 4, APRIL, 1980
of
fibrosis
with
hyperinflation.3’
sies
Simi-
which
473),
with progressed
had
evidence
showed
an
active
bronchiolitis patients
of
airways.
and
ob-
and
as-
idiopathic
restrictive spirometric
in small
of dis-
to the
McCarthy
patients rapidly
both
there
airways
contribute
initially had normal timed
an obliterative Both
Although
of obstruction pulmonary
of small
probably
two
to airflow in each
lung.M
( see page
fibrosis
addition,
tance
of
mechanism of interstitial
narrowing
recoil
Both patients defects (with
brosis.
airways.23
areas
and
X
intrinsic
In this issue sociates describe
in
the
histiocytosis
loss of elastic tructi618
persensitivity
is
dense
are scant data on the airflow in these forms
monary
pneumonitis,
are lesions
larly, chronic obstruction of airflow may be present in patients with chronic hypersensitivity pneumonitis,m some of the inorganic dust diseases,tm and
to have physiologic alterations consistent with disease of the small airways.2123 A bronchiolo-alveolitis, the characteristic morphologic finding of hyequivalent of such functional abnormalities. larly, the early morphologic change of disease is the coal macula which involves
there cystic
pul-
to COPD.
ventilatory data), but, increased
resis-
Pulmonary
biop-
alveolitis
and
either
or endobronchiolar
were
fi-
treated with corticosteSix to 12 months later,
roids and improved initially. both had physiologic, clinical, and radiographic findings typical of COPD. Pressure-flow studies indicated that a reduction in flow during maximum expiration was due mainly to reduced elastic recoil and increased dynamic compression. These data would be consistent with emphysema. The report of McCarthy et a! and the data cited in this editorial strongly support the concept that there are distinclive similarities between the interstitial and obstructive
pulmonary
diseases.
The
report
by McCarthy
et
al also raises questions on the possibility of acute interstitial injury as a cause for COPD. It is well documented that acute bronchiolar injury can lead to COPD, for example, that resulting from acute inhalation of smoke.36 Could an acute viral alveolitis and bronchiolitis or subclinical idiopathic pulmonary fibrosis do the same? Current data suggest that lobar emphysema is associated with acute viral pneumonias.37 Certainly, influenza can be associated with physiologic alterations consistent with disease of the small airways. This type of injury in the susceptible person may lead to classic COPD or to chronic obstructive disease of the small airways, as described by Macidem and colleagues.39 Recently, Miller et al’#{176} suggested that sarcoidosis may
The raises Ostrow
ment
cause
diffuse
report important and
in the
bullous
by
emphysema.
McCarthy therapeutic
Cherniack9
physiologic
and
and associates also questions. Whereas we12
observed
abnormalities
improve-
of small
SMALL AIRWAYS AND INTERSTITIAL PULMONARY DISEASE
air471
ways
on
treatment of McCarthy
patients pulmonary
This
disease
suggests
versibly
with corticosteroids, et al developed despite
that
corticosteroid
most
damaged,
small
perhaps
with have
ess?
Of
importance
the
overall
interstitial
be
greater
significance
actively
of
knowledge
distinction
diseases
of them
Could
synthesis, the disease
secreproc-
question
airway
we
of
less
the “indiseases.
these distinct
two as
our
increases. Jack
D. Fulmer,
M.D.,
F.C.C.P.*
Birmingham,
and
in
should
alveolar
repair in both pulmonary
between
of
disease
Clearly,
becomes
irre-
fibrosis.
mechanisms
injury and “obstructive”
functional
classes
were
is the
disease.
investigating
and bronchiolar terstitial” and
The
collagen altered of small
pulmonary
treatment.
airways with
agents that interfere lion, or cross-linking even
the two obstructive
William
C. Roberts,
M.D.,
Ala
Md
#{176}Veterans Administration Medical Center and Department of Medicine, University of Alabama. #{176}Pathology Branch, National Heart, Lung, and Blood Institute. Reprint requests: Dr. Fulmer, Department of Medicine (Putmot3ary), University of Alabama Medical Center, Binningham 35294 REFERENCES
1 Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278:1355-60. 2 Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary function tests. N Engl J Med 1977; 298:1277-81. 3 Thurlbeck WM. Changes in lung structure. In: Macklem PT, Permutt 5, eds. The lung in the transition between health and disease. New York: Marcel Dekker, Inc, 1979:17-41. 4 Macklem PT. Changes in lung mechanics: pressure-volume and pressure-flow relations. In: Macklem PT, Permutt 5, eds. The lung in the transition between health and disease. New York: Marcel Dekker, mc, 1979:53-71. 5 Kuhn C, Senior RM. The role of elastases in the development of emphysema. Lung 1978; 155:185-97. 6 Fulmer JD, Crystal RG. Interstitial lung diseases. In Simmons DE, ed. Current pulmonology. Boston: Houghton Mi.fflin Professional Publishers, 1979; 1: 1-65. 7 Haminan L, Rich AR. Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hosp 1944; 74:177-212. 8 Liebow AA, Carrington CB. Alveolar diseases: the interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, eds. Frontiers of Pulmonary Radiology. New York: Grune and Stratton, Inc, 1967: 102-41. 9 Ostrow D, Cherniack RM. Resistance to airflow in patients with diffuse interstitial lung disease. Am Rev Respir Dis 1973; 108:205-10. 10 Yernalt JC, Dejoinghe M, DeCoster A, et al. Pulmonary mechanics in diffuse fibrosing alveolitis. Bull Physicpathol Respir 1975; 11:231-44. 11 Roberts WC. Histologic observations in idiopathic pul.
FULMER, ROBERTS
1977;
20:1071-9.
14 Wohlgelernter D, Loke J, Matthay BA, et al. Systemic and discoid lupus erythematosis: analysis of pulmonary function. Yale J Biol Med 1978; 51:157-64. 15 Bombardieri 5, Paoletti P, Fern C, et aL Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979; 66:748-55. 16 Young RC Jr, Carr C, Shelton TG, et aL Sarcoidosis: relationship between changes in lung structure and function. Am Rev Respir Dis 1967; 95:224-38. 17
F.C.C.P.#{176}#{176} Bethesdtz,
472
monary fibrosis. (pp 773-776). In: Crystal RG (moderator). Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85:769-88. 12 Fulmer JD, Roberts WC, Von gal ER, et al. Small airways in idiopathic pulmonary fibrosis: comparison of morphologic and physiologic observations. J Clin Invest 1977; 60:595-610. 13 Guttadauria M, Ellman H, Emmanuel G, et aL Pulmonary function in scieroderma. Arthritis Rheumatism
Young
BC
trypsin
levels
tivity.
Chest
Jr,
Headings
VE,
in sarcoidosis 1973;
Bose
5,
: relationship
et
al.
Alpha-i
to disease
antiac-
64:39-45.
18 Kaneko K, Sharma OP. Airway obstruction in pulmonary sarcoidosis. Bull Eur Physiopathol Respir 1977; 13:23140. 19 Levinson RS, Metzger LF, Stanley NN, et al. Airway function in sarcoidosis. Am J Med 1977; 62:51-9. 20 Carrington CB, Gaensler EA, Mikus JP, et aL Structure and function in sarcoidosis. NY Acad Sci 1976; 278: 265-83. 21 Allen DH, Williams CV, Woolcock AJ. Bird breeders’ hypersensitivity pneumonitis: progress studies of lung function after cessation of exposure to the provoking antigen. Am Rev Respir Dis 1976; 114:555-66. 22 Jodoin C, Gibbs GW, Macklem PT, et al. Early effeots of asbestos exposure on lung function. Am Rev Respir Dis 1971; 104:525-35. 23 Seaton A, Lapp NL, Morgan WKC. Lung mechanics and frequency dependence of compliance in coal miners. J Clin Invest 1972; 51:1203-11. 24 Seal RME, Hapke EJ, Thomas GO, et al. The pathology of the acute and chronic stages of farmers lung. Thorax 1968; 23:469-89. 25 Schofield NM, Davies RJ, Cameron IR, et al. Small airways in fibrosing alveolitis. Am Rev Respir Dis 1976; 113:729-35. 26 DeTroyer A, Yernalt JC, Dierekx P, et al. Lung and airways mechanics in early pulmonary sarcoidosis. Bull Eur Physiopathol Respir 1978; 14:299-310. 27 Bjerke 1W, Tashkin DP, Clements DJ, et aL Small airways in progressive systemic sclerosis. Am J Med 1979; 66:201-9. 28 Fulmer JD, Roberts WC, Von Gal ER, et al. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979; 63:665-76. 29 Gaensler EA, Carrington CB, Coutu RE, et aL Radiographic physiologic-pathologic correlates in interstitial pneumonias. Prog Respir Res 1975; 8:223-41. 30 Miller A, Teirstein AS, Jackler I, et aL Airway function in chronic pulmonary sarcoidosis with fibrosis. Am Rev Respir Dis 1974; 109:179-89. 31 DeRemee BA, Andersen HA. Sarcoidosis: a correlation
of
dyspnea
tion
32
Braun
with
changes.
SR,
radiographic
Mayo Clin Proc doPico GA, Tsiatis
stage
and
pulmonary
1974; 49:742-5. A, et a!. Farmer’s
func-
lung
CHEST, 77: 4, APRIL 1980
disease:
Rev
clinical
long-term
physiologic
and
outcome.
Am
1979; 119:185-91. 33 Morgan WKC, Seaton A. Occupational lung diseases. Philadelphia: WB Saunders Co, 1975: 132-4, 174-92. 34 Basset F, Corrin B, Spence H, et al. Pulmonary histiocytosis X. Am Rev Respir Dis 1978; 118:811-20. 35 Leaver DG, Tattersfield AE, Pride NB. Contributions of loss of lung recoil and of enhanced airways collapsibility to the airflow obstruction of chronic bronchitis and emphysema. J Clin Invest 1973; 52:2117-34. 36 Kirkpatrick MB, Bass JB. Severe obstructive lung disease after smoke inhalation. Chest 1979; 76:108-10. Respir
Chronic
Obstructive
following
Idiopathic
D. S. McCarthy, E.
S.
M.D.,
development
fibrosis
bronchioles.1 patients
process involves et
this
a!2
M.D.,
lung
evidence
of
as that
reported had
see page
pulmowell
as 17
the
of
pathologic
18 and
470
bronchiolar
disease.
Other
authors idiopathic
have reported small airways disease in pulmonary fibrosis3 and other idiopathic disease involving the lung parenchyma such as pulmonary sarcoidosis4’5 and progressive systemic sclerosis.6’7 This report describes the rapid development of irreversible airflow obstruction in two middle-aged nonsmoking
women
who
and radiologically from fibrosis ( Hamman-Rich CASE CASE
recovered
clinically
acute idiopathic disease).
had
pulmonary
REPORTS
1
A 58-year1ld an eight-week From
the
housewife was admitted to the hospital history of progressive cough productive Respiratory
of Manitoba, #{176}#{176}Associate Professor. University
tAssistant Manuscript
Professor. received
May
74:167-77.
MT. The sarcoidosis:
AS, Chuang in pulmonary
stages
and
to
response
of
sequence correlation therapy.
Mt
44:852-65.
F.C.C.P.;t
obstruction
idiopathic
alveoli
diagnosis
For commentary, physiologic
1971;
Miller A, Teirstein physiologic changes with radiographic Sinai J Med 1977;
40
Fibrosis*
airflow
in
the
Fulmer with
39
F.C.C.P.#{176}#{176}
of irreversible
inflammatory
nary
38
Pulmonary
two nonsmoking women who recovered from acute Idiopathic pulmonary fibrosis is discussed. Pulmonary fibrosis was diagnosed clinically and by lung biopsy. Recovery both dilnicaDy and radiologically was complete. Several pulmonary function studies in both patients showed a typical restrictive pattern (reduced
he
BC,
Disease
In
T
Fraser
Philadelphia:
Pulmonary
M.D.;#{176}#{176} D. N. Ostrow,
Hershfield,
The rapid
Pare j s.p. Diagnosis of diseases of the chest WB Saunders Co, 1979; 3:1431. Little JW, Hall WJ, Douglas BC, et al. Amantadine effeet on peripheral airways abnormalities in influenza. Ann Intern Med 1976; 85:177-82. Maddem PT, Thurlbeck WM, Fraser BC. Chronic obstructive disease of small airways. Ann Intern Med
37
Dis
Section, Department Winnipeg, Manitoba, 10;
CHEST, 77: 4, APRIL, 1980
revision
accepted
with of 3
of Medicine, Canada. June
27.
normal
volumes
and
FEV1/FVC
tients exhibited (hyperinflation, ments). These
dioxide
carbon ratio).
Within
diffusing
one
year
capacity, both pa-
an obstructive pattern of dysfunction gas trapping, reduced airflow measurepatients illustrated Irreversible airway
obstruction following recovery of pulmonary fibrosis.
from
the
restrictive
stage
cup mucopurulent sputum per day, feverishness and increasing shortness of breath and fatigue with a weight loss of 3.5 kg. There was no history of chest pain, wheezing, swelling of anides or joints. Past history was non-contributory. The patient did not smoke, had no allergies, and had been a housewife all her adult life. There was no known exposure o noxious inhalants. On physical examination, the patient was found to be of average nutrition, temperature 38.8#{176}C,pulse rate 108, respirations 24/rain, blood pressure 110/70 mm Hg. The trachea was deviated to the right; there was no clubbing of digits. Chest movements and air entry were diminished over the right lung, and there was dullness to percussion and increased tactile vocal fremitus on the right side. Mid and late inspiratory crackles were present over both lungs, especially the lower lobes. No clinical evidence of airways obstruction was found. Other systems were normal. The roentgenogram taken on admission showed bilateral lung infitrations, especially on the right side. A chest film had been taken 15 months earlier because of unrelated problems but showed normal findings. Because of difficulty in establishing a diagnosis, lung biopsy was performed through a small right thoracotomy. On inspection the lung was unremarkable and a biopsy was taken from the right upper lobe. The biopsy revealed diffuse disease with interstitial fibrosis and pronounced epithelial hyperplasia of the alveolar walls. There were numerous subepithelial collections of foamy macrophages and many free alveolar phagocytes ( Fig 1A). Several wide bands of fibrosis were seen and vascular sclerosis was pronounced. The respiratory bronchioli showed changes of obliterative bronchiolitis (Fig 1B). No granulomath were seen.
The
patient
was
treated
with
antibiotics,
but showed
COPD FOLLOWING IDIOPATHIC PULMONARY FIBROSIS
no
473